Navigation Links
Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
Date:10/5/2007

COLLEGEVILLE, Pa., Oct. 5 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), presented new data today from two Phase 3 studies, which showed that bazedoxifene/conjugated estrogens reduced the number and severity of hot flashes in symptomatic postmenopausal women by up to 80 percent, when compared with placebo. These data, presented at the North American Menopause Society Annual Meeting, also showed that bazedoxifene/conjugated estrogens improved symptoms of vulvar and vaginal atrophy. In addition, secondary data from both studies showed that when compared with placebo, bazedoxifene/conjugated estrogens reduced sleep disturbances and improved menopause-related quality of life.

"The pairing of bazedoxifene, a selective estrogen receptor modulator, or SERM, with conjugated estrogens may lead to a new class of menopausal therapy called tissue selective estrogen complex, or TSEC," says Ginger Constantine, M.D., Vice President, Women's Health Care and Bone Repair, Wyeth Pharmaceuticals. "TSECs pair the benefits of estrogens with SERMs to create a distinct clinical profile, which may provide relief of hot flashes and vaginal dryness as well as bone and uterine protection."

Update on NDA Filing

Wyeth plans to submit its New Drug Application (NDA) to the U.S. Food and Drug Administration for bazedoxifene/conjugated estrogens in the second quarter of 2008 subject to the further analysis and successful completion of product formulation, bioequivalence and clinical studies, and other remaining work necessary to finalize the NDA.

Significant Reduction of Hot Flashes and Relief of Vulvar and Vaginal Atrophy Symptoms

Results of a clinical trial titled "A Phase 3 Study of th
'/>"/>

SOURCE Wyeth
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
2. Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ANKLIN,Mass.,Nov.24/PRNewswire-FirstCall/--EchoThe...lopingitsneedle-freeSymphony(TM)tCGMSystemasanon-i...oring(tCGM)systemanditsPrelude(TM)SkinPrepSystemfo...T.Mooney,M.D.,ChairmanandChiefExecutiveOfficer,wil...uticalsConference,sponsoredbytheNewYorkSocietyofSe...
(Date:11/24/2009)...RSAW,Ind.,Nov.24/PRNewswire-FirstCall/--ZimmerHold...eparticipatinginthe21stAnnualPiperJaffrayHealthCar...00a.m.EasternTime. ,, Alivewebcastofthepresenta...teat http://investor.zimmer.com .Thewebcastwillbea...uttheCompany ,, Foundedin1927andheadquarteredi...
(Date:11/24/2009)...NDIEGO,Nov.24/PRNewswire-FirstCall/--OptimerPharma...tthe21stAnnualPiperJaffrayHealthCareConferenceatTh....m.EasternTime. ,, (Logo: http://www.newscom.co...udiowebcastofthispresentationwillbeaccessibleonthe...harma.com .Replaysofthispresentationwillbeavailab...
Breaking Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Chewing Tobacco No Safer Than Smoking 54635 1Chewing Tobacco No Safer Than Smoking 54635 2Department of Health Releases Guidance on Novel H1N1 Influenza for Schools K 12 54633 1Department of Health Releases Guidance on Novel H1N1 Influenza for Schools K 12 54633 2Department of Health Releases Guidance on Novel H1N1 Influenza for Schools K 12 54633 3AccuVein Sells Multiple AV300s to First European Customer 54630 1AccuVein Sells Multiple AV300s to First European Customer 54630 2
...als, Inc. (Nasdaq: ISTA ), today presented resul...ilate ophthalmic solution) Phase 3 pivotal clinica...e (CAC) model of allergic conjunctivitis. The stu...ducing ocular itching for at least 8 hours after d...ovement in ocular itching compared to placebo for ...
...te Special Committee on Aging Chairman Herb Kohl (...Charles Grassley (R-IA), Johnson & Johnson tod...s Sunshine Act of 2009 (S. 301). The company also ... made to physicians by its U.S. pharmaceutical, me...re in favor of greater transparency regarding the ...
Other Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting 3Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 2Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 3
(Date:11/24/2009)...y help ward off peripheral artery disease, resear...y News) -- Among people aged 75 and older, the her...t attacks, stroke or death, a new study finds. ,...emedy might help prevent the leg-circulation probl..., Ginkgo contains nutrients called flavonoids, wh...
(Date:11/24/2009)...have found that hormones produced during pregnancy...h of breast cancer. This protein, alpha-fetoprotei...nt for the treatment and prevention of breast canc...vention Research , a journal of the American Assoc...nancy, such as estrogen, all induce AFP, which dir...
(Date:11/24/2009)...swire-USNewswire/--Thereisanewgameintownwhenitcome...feringpragmaticandrealisticstrategieswheretraditio...ingthismovementisagroupcalledHAMS--HarmReduction,A...f-charge,lay-ledsupportandinformationalgroupforpeo...coholAbuseandAlcoholismtellsusthatonly7%ofpeoplewi...
(Date:11/24/2009)...PRNewswire/--Thankstoaninnovativeprogramrecentlyde...ndAnthemBlueCrossandBlueShieldinMaine,someAnthemme...cianwithoutleavinghome. ,, Aspartofthepilot,Ant...stionsandcommunicateviaemailwiththeirproviderabout...nts,checkingontestresults,orrequestingprescription...
(Date:11/24/2009)...ts Conjoint Mid-Winter Meetings Jan. 27Feb. 2, 201...rque, N.M. This year, SNM joins its annual Mid-Win...ting and Educational Symposium of the American Col...and Molecular Imaging Summit and the Clinical Tria... offers participants an outstanding range of scien...
Breaking Medicine News(10 mins):Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Protein from pregnancy hormone may prevent breast cancer 2Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2Health News:The Doctor Will See You Now. . .Online 2Health News:SNM's Conjoint Mid-Winter Meetings offer 4 scientific meetings in 1 location 2
...abetes in the US is out. Spending on diabetes drug...g to a drug trend report released by the Medico He...cholesterol medications in total prescription drug... rates on diabetes drugs up 16 percent to 20 perce...
...gnatures of effective, real-time coordination betw... both behavior and brain activity simultaneously ... a specially designed dual-electroencephalogram (E...blished in the May 8, 2007 Proceedings of the Nati...
...rincess Margaret Hospital have successfully proven...ncer drug that is triggered by a laser light, a p... In a study published today in the Proceedings o... Ball Chair for Prostate Cancer Research - Ontario...
...hat self-confidence can translate into earning hun.... Believing in yourself really does work wonders...d. People with high opinions of themselves...eged backgrounds. Timothy Judge, a UF m...
... pregnancy could be extremely beneficial for babie...lready linked to better lung health when taken by ...s, and oily fish in particular contain Omega-3 oil...zed 2,000 pregnant women on their eating habits, a...
...hat it has a mix of properties that would not othe...trix with metallic clusters that can absorb light...o cells and then destroy those targeted cells with...get and destroy melanoma cancer cells. Com...
Other Medicine News:Health News:Spending on Diabetes Drugs Soars in US 2Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 2Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 3Health News:Scientists Activate New Cancer Drug Using Light and Oxygen 2Health News:Teenage Self Confidence Can Translate Later into Material Wealth 2Health News:Teenage Self Confidence Can Translate Later into Material Wealth 3Health News:Nanocomposite Labeled Cancer Cells Targeted and Destroyed by Using Lasers 2
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: